Drug Development TechnologyNews and commentary for the Drug Development Technology community.BIOALVO SA FILED PATENTS COVERING FIRST DRUG PRODUCTS- June 26, 2008 Showing the efficacy of its HTS screening systems and successful collaboration with Academia, Bioalvo managed to file its first IP on products eight months after having the technology platform up and running. Bioavlo filed two PCT patent applications covering the therapeutic use of a compound identified using its proprietary drug screening technology, already protected by two earlier filed PCT applications. Relevant data regarding toxicity, efficacy and physiological behaviour (like ability...http://www.drugdevelopment-technology.com/contractors/clinical_development/bioalvo/press1.... Hyetts Express Deliveries- June 26, 2008 Hyetts' fleet enable temperature critical medical and healthcare products to be delivered safely, at the right time and at the correct temperature throughout the UK and across Europe. Hyetts' Express Delivery fleet provide temperature controlled vehicles specialising in: Multi-temperature deliveries Temperature-critical pharmaceutical deliveries Same day next day emergencies Clinical trial deliveries Named patients hospitals doctors surgeries pharmacies Sample deliveries Guaranteed.http://www.drugdevelopment-technology.com/contractors/delivery/hyetts-express ReseaChem- June 26, 2008 ReseaChem was founded in 1996. It was established by Dr. Franz Baumberger and Stefan Berger as a spin-off from the then engineering school, Burgdorf. With the launch of the 24 hour NMR service in 1998, it set a milestone in Switzerland with regard to speed for complex services. After starting synthesis of RNA components and natural materials in 2000, the main focus was placed, from very early, on life science. This was continued with the introduction of a routine isolation of natural materials.http://www.drugdevelopment-technology.com/contractors/organic/resea 21st Century Biochemicals- June 26, 2008 21st Century Biochemicals was founded by PhD scientists with over 100 years of combined experience in peptide chemistry, immunology, mass spectrometry, biochemistry, neuroscience, and cell biology. They have become a trusted partner for pharmaceutical forms, biotech companies, and academic laboratories around the globe for several key reasons: Unparalleled product quality and the most rigorous quality control in the industry Customer service that is second to none Scientific acumen that our..http://www.drugdevelopment-technology.com/contractors/synthesis/21stcenturybio Pradaxa - Oral Direct Thrombin Inhibitor- June 24, 2008 Pradaxa (dabigatran etexilate) is a new oral anticoagulant under development by Boehringer Ingelheim. Its primary indication is for prevention of venous thromboembolism (VTE) following orthopaedic surgery, such as operations for total hip and total knee replacement. Within a year of filing for regulatory approval with the EMEA in early 2007, the company received positive news that the Committee for Medicinal Products in Human Use (CHMP) had recommended Pradaxa's approval for...http://www.drugdevelopment-technology.com/projects/pradaxa/ IDBS Founder and CEO is Awarded Honorary Doctorate- June 19, 2008 IDBS is today proud to announce Neil Kipling, founder and CEO, has been awarded an honorary doctorate (DUniv) from the University of Surrey. Since being founded by Neil Kipling in 1989, IDBS has grown to become one of the world's leading providers of data management software to the pharmaceutical and biotechnology industries. The company has been trading for almost 20 years in a highly competitive marketplace and boasts an enviable customer base that includes 18 of the top 20 global...http://www.drugdevelopment-technology.com/contractors/it/id/press31.html If Low Flow Isn't for You, Aim Higher - High Volume, High Pressure and High Purity Nitrogen- June 18, 2008 We are proud to present you our new ultra high purity nitrogen gas generator for Gas Chromatography systems. The NG10L-HP is designed to deliver high volume, high pressure, clean, dry, Nitrogen at a flow rate of 10lmin for the use with multiple Laboratory Analytical Instruments as a source of carrier gas. This system utilizes carbon molecular sieve technology to selectively remove oxygen, moisture and other gases to leave clean, dry, phthalate free, ultra high purity nitrogen. Due to the...http://www.drugdevelopment-technology.com/contractors/lab_equipment/peak/press7.html IDBS Receives Prestigious Frost & Sullivan Industry Award- June 18, 2008 Guildford, UK - ID Business Solutions Ltd (IDBS), a provider of drug discovery data management solutions, is proud to be awarded the 2008 Frost & Sullivan European Bioinformatics Service Differentiation Innovation Award. Analysts from Frost & Sullivan perform extensive market research in order to determine potential award recipients. Their research indicated that 'IDBS provides real value to the life sciences industry through its consulting services.' By enabling the companies in the life...http://www.drugdevelopment-technology.com/contractors/it/id/press30.html Motavizumab - New Biological Therapy for RSV Prevention- June 9, 2008 Developed by MedImmune (now wholly owned by AstraZeneca), motavizumab is an investigational monoclonal antibody (MAb) indicated for the prevention of respiratory syncytial virus (RSV) infection in high-risk infants. Following the successful outcome of large-scale phase III paediatric clinical trials, a Biologics License Application (BLA) was submitted to the FDA to seek approval to market motavizumab for RSV prevention. "RSV is the most common cause of bronchiolitis and pneumonia in infants...http://www.drugdevelopment-technology.com/projects/nrimotovizumab/ ASINEX's Launches In-Vitro Metabolism Screening Service- June 3, 2008 As part of ASINEX's suite of ADMET screens, ASINEX is able to provide affordable, efficient non-GLP tests for Liver S9 stability (human, rat), stability in hepatocytes (human, rat), plasma protein binding (rat) and plasma stability (rat).The tests are carried out at ASINEX's laboratory in Moscow where turnaround time is typically from 4-10 days depending on the test. ASINEX is able to provide special offers for first time users. ASINEX's Bioscreening dept. was founded in 2001 and provides a...http://www.drugdevelopment-technology.com/contractors/contract_research/asinex/press1.html |